Therapeutic Potential of GLP-1 Receptor Agonists in Diabetes and Cardiovascular Disease: Mechanisms and Clinical Implications
its creating a support system that includes nutrition guidance, exercise plans, and ongoing accountability
GLP-1 stimulates insulin secretion when blood glucose levels are elevated, suppresses glucagon release, and slows gastric emptying
This correlation between GLP-1-based therapies and mental well-being is important in understanding the intersecting realms of diabetes management and mental health
Considering the expense of these medications is vital when selecting treatment
Another adverse impact of this shortage, she said, is that patients have lower compliance levels with a daily injectable medication, compared to a weekly one.